![Thomas George MD, FACP on X: "O'Reilly: If you have #PancreaticCancer, know your MSI and BRCA status! It could significantly change your treatment plan. #ASCO18 #PancSM https://t.co/kXXTaDdfCx" / X Thomas George MD, FACP on X: "O'Reilly: If you have #PancreaticCancer, know your MSI and BRCA status! It could significantly change your treatment plan. #ASCO18 #PancSM https://t.co/kXXTaDdfCx" / X](https://pbs.twimg.com/media/DeuElcyWsAAWsjC.jpg)
Thomas George MD, FACP on X: "O'Reilly: If you have #PancreaticCancer, know your MSI and BRCA status! It could significantly change your treatment plan. #ASCO18 #PancSM https://t.co/kXXTaDdfCx" / X
![OS From the Phase 3 POLO Trial: Maintenance Olaparib for Germline BRCAm Metastatic Pancreatic Cancer | VuMedi OS From the Phase 3 POLO Trial: Maintenance Olaparib for Germline BRCAm Metastatic Pancreatic Cancer | VuMedi](http://media.vumedi.com/thumbs/video/2022/4/e58bae58-2bce-4635-954e-5d347520db81.300x170_q85_crop-smart_upscale.jpg)
OS From the Phase 3 POLO Trial: Maintenance Olaparib for Germline BRCAm Metastatic Pancreatic Cancer | VuMedi
♠️Spade TV on Instagram: "Young Thug's attorney wants YSL Polo removed from Thug's trial due to his “unacceptable conduct” ."
![Olaparib maintenance therapy improves PFS in BRCA-mutated metastatic pancreatic cancer | Latest news for Doctors, Nurses and Pharmacists | Pharmacy Olaparib maintenance therapy improves PFS in BRCA-mutated metastatic pancreatic cancer | Latest news for Doctors, Nurses and Pharmacists | Pharmacy](https://pubmiddleware.mims.com/resource/image/5d37645d-79da-4d04-a642-aa9700099f25/OriginalThumbnail/THUMBNAIL_Lynparza%20HK-AST-337mo4.jpg)
Olaparib maintenance therapy improves PFS in BRCA-mutated metastatic pancreatic cancer | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
![Vinay Prasad MD MPH on X: "The POLO trial is not suited to change practice. As we write in the journal Cancer https://t.co/nn5RnTdYpO https://t.co/BOKyjycSrj" / X Vinay Prasad MD MPH on X: "The POLO trial is not suited to change practice. As we write in the journal Cancer https://t.co/nn5RnTdYpO https://t.co/BOKyjycSrj" / X](https://pbs.twimg.com/media/EiUnbXtU4AAwKpB.jpg:large)
Vinay Prasad MD MPH on X: "The POLO trial is not suited to change practice. As we write in the journal Cancer https://t.co/nn5RnTdYpO https://t.co/BOKyjycSrj" / X
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer on Vimeo
![Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2022/jco.2022.40.issue-34/jco.21.01604/20221116/images/large/jco.21.01604t1.jpeg)